Related Experiment Video

Updated: Sep 12, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K

[Management of Risk Factors and Comobordities in Atrial Fibrillation]

Melanie Gunawardene, Boris Schmidt

    Deutsche Medizinische Wochenschrift (1946)
    |August 5, 2025
    PubMed

    Insights

    Atrial fibrillation (AF) is a common heart rhythm disorder influenced by age, genetics, obesity, and alcohol. Treating these factors and related conditions improves AF management and outcomes.

    Area of Science:

    • Cardiology
    • Electrophysiology
    • Public Health

    Context:

    • Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia, with increasing significance due to demographic shifts.
    • AF development is multifactorial, influenced by non-modifiable (age, genetics) and modifiable (obesity, alcohol) risk factors.
    • Key comorbidities associated with AF include hypertension, heart failure, sleep apnea, and diabetes mellitus.

    Purpose:

    • To review the multifactorial etiology of atrial fibrillation.
    • To highlight the impact of managing risk factors and comorbidities on AF progression and treatment outcomes.
    • To emphasize the importance of guideline-recommended, interdisciplinary treatment strategies for AF.

    Summary:

    • Atrial fibrillation (AF) is a complex arrhythmia influenced by numerous factors, including age, genetics, lifestyle choices, and co-existing medical conditions.
    • Effective management of AF involves addressing both non-modifiable and modifiable risk factors, alongside treating common comorbidities like hypertension and diabetes.
    • Preventive strategies and comprehensive, interdisciplinary care are crucial for improving AF management and achieving therapeutic goals.

    Impact:

    • Highlights the critical role of lifestyle modifications and comorbidity management in preventing AF progression.
    • Underscores the effectiveness of integrated, multidisciplinary approaches in optimizing rhythm control therapy for atrial fibrillation.
    • Provides evidence supporting guideline recommendations for a holistic treatment strategy in atrial fibrillation management.

    More Related Videos

    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

    The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

    Published on: February 28, 2012

    83.9K
    Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation08:10

    Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

    Published on: July 20, 2022

    1.8K

    Related Concept Videos

    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
    35
    Dysrhythmias VI: Management of Dysrhythmias01:25

    Dysrhythmias VI: Management of Dysrhythmias

    Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
    107
    Aortic Regurgitation III: Medical Management01:25

    Aortic Regurgitation III: Medical Management

    Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
    43
    Mitral Stenosis III: Medical Management01:26

    Mitral Stenosis III: Medical Management

    Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
    21
    Atherosclerosis IV: Nursing Management01:23

    Atherosclerosis IV: Nursing Management

    Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
    51
    Rheumatic Heart Disease III: Medical Management01:21

    Rheumatic Heart Disease III: Medical Management

    Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
    32